A Phase I Trial of Satraplatin Plus Radiation Therapy for Prostate Cancer Patients With Biochemical Recurrence Following Radical Prostatectomy.
Phase of Trial: Phase I
Latest Information Update: 22 Mar 2012
At a glance
- Drugs Satraplatin (Primary)
- Indications Prostate cancer
- Focus Adverse reactions
- Sponsors GPC Biotech Inc
- 31 Aug 2018 Biomarkers information updated
- 05 Feb 2008 Status changed from recruiting to discontinued. Updated from ClinicalTrials.gov.
- 10 Sep 2007 Status changed from initiated to recruiting.